FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Empower Pharma | 831178947 | 72627-2441 | 72627-2441-2 | Methionine; Choline Chloride; Cyanocobalamin | 25 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL | 2026-1 | valid | 2026-10-06 | |
| Empower Pharma | 831178947 | 72627-2441 | 72627-2441-1 | Methionine; Choline Chloride; Cyanocobalamin | 25 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL | 2026-1 | valid | 2026-10-06 | |
| Empower Pharma | 72627-2441 | 72627-2441-1 | Methionine/Choline Chloride/Cyanocobalamin | Methionine/Choline Chloride/Cyanocobalamin | 25 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL | 2026-1 | valid | 2026-09-18 | |
| Empower Pharma | 72627-2441 | 72627-2441-2 | Methionine/Choline Chloride/Cyanocobalamin | Methionine/Choline Chloride/Cyanocobalamin | 25 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL | 2026-1 | valid | 2026-09-18 | |
| Empower Pharma | 831178947 | 72627-2441 | 72627-2441-1 | Methionine; Choline Chloride; Cyanocobalamin | 25 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL | 2025-2 | valid | 2026-10-06 | |
| Empower Pharma | 72627-2441 | 72627-2441-1 | Methionine/Choline Chloride/Cyanocobalamin | Methionine/Choline Chloride/Cyanocobalamin | 25 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Empower Pharmacy | 831178947 | 72627-2441 | 72627-2441-1 | Methionine; Choline Chloride; Cyanocobalamin | 25 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL | 2023-1 | valid | 2026-10-06 | |
| Empower Pharmacy | 831178947 | 72627-2441 | 72627-2441-1 | Methionine; Choline Chloride; Cyanocobalamin | 25 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL | 2022-2 | valid | 2026-10-06 |